HARRISBURG, Pa., Oct. 2, 2024 /PRNewswire/ -- Ambetter from PA Health & Wellness, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the Pennsylvania Health Insurance Exchange, will offer a variety of affordable health insurance plans to Pennsylvanians in 30 counties in plan year 2025. Open enrollment for the Health Insurance Marketplace for Pennsylvania runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15, 2024, for coverage starting Jan. 1, 2025.
Ambetter from PA Health & Wellness now will be available in 11 central and western Pennsylvania counties, with locations in Altoona, Clarion, Greensburg, Latrobe, State College and Uniontown.
"Ambetter from PA Health & Wellness has the high-quality healthcare coverage options and the providers you want and need," said Plan President and Chief Executive Officer of PA Health & Wellness, Justin Davis. "With plans designed to fit different budgets and lifestyles, Ambetter from PA Health & Wellness has you covered, and we're excited to bring these to the people of central and western Pennsylvania."
Ambetter from PA Health & Wellness offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:
Below is a full list of counties in which Ambetter Health from PA Health & Wellness will be offered in 2025:
Pennsylvania residents interested in learning more about Ambetter from PA Health & Wellness or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/pa/
About Ambetter from PA Health & Wellness
Ambetter from PA Health & Wellness serves under-insured and uninsured populations through the Pennsylvania State Based Exchange, Pennie. Ambetter from PA Health & Wellness is underwritten by Pennsylvania Health & Wellness, Inc., which is a Qualified Health Plan issuer in Pennsylvania. For more information, visit ambetterhealth.com/en/pa. This is a solicitation for insurance. For information on your right to receive an Ambetter from PA Health & Wellness plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$29.04 |
Daily Change: | 0.66 2.33 |
Daily Volume: | 7,803,803 |
Market Cap: | US$14.260B |
July 29, 2025 July 25, 2025 April 25, 2025 February 24, 2025 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load